<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">

Immuno-oncology

OX40 Agonists: Boosting Cancer Immunotherapy

7 minute read

OX40 Agonists: Boosting Cancer Immunotherapy

October 18, 2024

Key Differences between hPBMC and hCD34 Humanized Mouse Models

6 minute read

Key Differences between hPBMC and hCD34 Humanized Mouse Models

July 10, 2024

Understanding the Cancer-Immunity Cycle to Improve Cancer Immunotherapy Development

6 minute read

Understanding the Cancer-Immunity Cycle to Improve Cancer Immunotherapy Development

July 11, 2023

Using Tumor Organoids and 3D Ex Vivo Microtumors for Immuno-Oncology Applications

9 minute read

Using Tumor Organoids and 3D Ex Vivo Microtumors for Immuno-Oncology Applications

June 22, 2022

How to Detect, Characterize, and Evaluate CAR-Ts: Top 13 Questions

4 minute read

How to Detect, Characterize, and Evaluate CAR-Ts: Top 13 Questions

October 5, 2021

Profiling of Tumor-Infiltrating Immune Cells in Syngeneic Tumor Models to Support Drug Development

4 minute read

Profiling of Tumor-Infiltrating Immune Cells in Syngeneic Tumor Models to Support Drug Development

March 1, 2021

The Rising Importance of GITR Agonists as Alternative I/O Candidates for Combination Drug Strategies

6 minute read

The Rising Importance of GITR Agonists as Alternative I/O Candidates for Combination Drug Strategies

November 30, 2020

Evaluating Immunotherapy Mechanism of Action with Immune Cell Lineage-Specific DTR Models

5 minute read

Evaluating Immunotherapy Mechanism of Action with Immune Cell Lineage-Specific DTR Models

October 14, 2020

T Cell Dysfunction Assays for In Vitro Screening of Immunomodulatory Drug Candidates

4 minute read

T Cell Dysfunction Assays for In Vitro Screening of Immunomodulatory Drug Candidates

September 22, 2020

Digital Pathology

7 minute read

Digital Pathology

July 23, 2020